Narcolepsy and Orexin Agonist in Boston Globe | Project Sleep
Learn more about the Boston Globe article featuring narcolepsy and orexin agonist research with Project Sleep Rising Voices speaker Katelynn O’Connell.| Project Sleep
The post Rising Voices Narcolepsy Story Sharing: Maha Awad appeared first on Project Sleep.| Project Sleep
Learn more about the Boston Globe article featuring narcolepsy and orexin agonist research with Project Sleep Rising Voices speaker Katelynn O’Connell.| Project Sleep
New research reveals how orexin deficiency may paradoxically improve glymphatic function when NT1 patients are awake.| Sleep Review
The seventh annual World Narcolepsy Day is September 22, 2025. Here are great ways to get involved and raise critical narcolepsy awareness.| Project Sleep
Avadel Pharmaceuticals has licensed valiloxybate from XWPharma Ltd.| Sleep Review
Learn more about Megan Donnell, a benefits consultant who joined Project Sleep's Board of Directors in August 2025.| Project Sleep
In July 2020, Rowin, a lively 6-year-old from Bozeman, Montana, began experiencing frequent and uncontrollable daytime naps. This disrupted his daily routine and concerned his family. Despite multiple visits to pediatricians and specialists, a definitive diagnosis remained mysterious. Frustrated by the lack of progress, Rowin’s family sought a referral to a sleep specialist in Bozeman.…| Rady Children's Health
Do you feel constantly tired? You may be suffering from a sleep disorder. Learn what to expect from a sleep study, and the available treatments.| www.wwmedgroup.com
The post SPANISH World Narcolepsy Day Story Sharing: Meet María José in Ecuador! appeared first on Project Sleep.| Project Sleep
The post World Narcolepsy Day Story Sharing: Meet Glenn in Australia! appeared first on Project Sleep.| Project Sleep
The post Narcolepsy Nerd Alert: Traveling with Narcolepsy appeared first on Project Sleep.| Project Sleep
In a sea of sleep-related content, we've curated a list of 12 sleep podcasts you might not know yet! Explore expert insights and patient perspectives.| Project Sleep
Alkermes’ alixorexton met primary and key secondary endpoints in a phase 2 trial for narcolepsy type 1, showing dose-dependent improvements.| Sleep Review
Takeda’s investigational orexin-2 receptor agonist oveporexton met all endpoints in two phase 3 trials for narcolepsy type 1.| Sleep Review
View Post The post Diagnosis: Narcolepsy appeared first on Mama In The Now.| Mama In The Now
